Genmab A (GMAB) Non-Current Assets (2019 - 2026)

Genmab A has reported Non-Current Assets for 6 years, with the latest figure at $9.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 1.85% year-over-year to $9.8 billion; the trailing twelve-month figure through Mar 2026 stood at $9.8 billion (down 1.85% YoY), and the FY2025 full-year result was $10.0 billion, up 297.3% from the prior year.
• Non-Current Assets for Q1 2026 stood at $9.8 billion, down from $10.0 billion in the prior quarter.
• The five-year high for Non-Current Assets was $10.0 billion in Q1 2025, with the low at $320.0 million in Q4 2023.
• Historically, Non-Current Assets has averaged $4.7 billion across 4 years, with a median of $2.6 billion in 2025.
• Annual changes were most pronounced in 2024 — Non-Current Assets jumped 685.62% — and 2026, when it decreased 1.85%.
• Genmab A's Non-Current Assets stood at $320.0 million in 2023, then jumped by 685.62% to $2.5 billion in 2024, then jumped by 297.3% to $10.0 billion in 2025, then fell by 1.85% to $9.8 billion in 2026.
• The last three Non-Current Assets figures came in at $9.8 billion (Q1 2026), $10.0 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.